HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nitric oxide-induced activation of NF-κB-mediated NMDA-induced CTP:phosphocholine cytidylyltransferase alpha expression inhibition in A549 cells.

Abstract
Pulmonary surfactant is a lipoprotein complex on the alveolar surface. It reduces the surface tension at the air-water interface and stabilizes the alveoli during expiration. Surfactant deficiency or dysfunction is associated with occurrence and development of many pulmonary diseases. Family members of CTP:phosphocholine cytidylyltransferase are rate-limiting enzymes for surfactant phospholipid synthesis. We had reported recently that the expression of CTP:phosphocholine cytidylyltransferase alpha (CCT-α) was inhibited during N-methyl-D: -aspartic acid (NMDA)-induced lung injury. But the molecular mechanism underlining remains elusive. In this work, we reported that NMDA induced nitric oxide synthase (NOS) activation and nuclear factor-kB (NF-κB) subunit p65 nuclear translocation in A549 cells, which were responsible for decreased (CCT-α) expression. Furthermore, NOS activation and elevated NO production are upstream regulators for p65 nuclear translocation and (CCT-α) expression inhibition. Our results provided important clues for further elucidating the mechanisms underlying glutamate-induced lung injury.
AuthorsLian Li, Li Shen, Hua She, Shaojie Yue, Dandan Feng, Ziqiang Luo
JournalCell biology and toxicology (Cell Biol Toxicol) Vol. 27 Issue 1 Pg. 41-7 (Feb 2011) ISSN: 1573-6822 [Electronic] Netherlands
PMID20661636 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • NF-kappa B
  • Nitric Oxide
  • N-Methylaspartate
  • Choline-Phosphate Cytidylyltransferase
  • PCYT1A protein, human
Topics
  • Choline-Phosphate Cytidylyltransferase (biosynthesis)
  • Gene Expression Regulation, Enzymologic
  • Humans
  • N-Methylaspartate (pharmacology)
  • NF-kappa B (physiology)
  • Nitric Oxide (physiology)
  • Signal Transduction
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: